A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST.
Peptide Assembly in Lysosomes Offers High Cancer Selectivity miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New treatment approach selectively targets cancer cell lysosomes and overcomes drug resistance medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
A research team, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has developed a groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance.
Cancer Targeted Chemotherapy Using Disassembly-Assembly Method miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.